EA201390003A1 - Пероральная терапия дефицита железа - Google Patents

Пероральная терапия дефицита железа

Info

Publication number
EA201390003A1
EA201390003A1 EA201390003A EA201390003A EA201390003A1 EA 201390003 A1 EA201390003 A1 EA 201390003A1 EA 201390003 A EA201390003 A EA 201390003A EA 201390003 A EA201390003 A EA 201390003A EA 201390003 A1 EA201390003 A1 EA 201390003A1
Authority
EA
Eurasian Patent Office
Prior art keywords
iron deficiency
oral treatment
iron
deficiency
normalize
Prior art date
Application number
EA201390003A
Other languages
English (en)
Other versions
EA026713B1 (ru
Inventor
Гари М. Райли
Паршурам Рат
Майкл Новински
Original Assignee
Эмисфире Текнолоджис, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эмисфире Текнолоджис, Инк. filed Critical Эмисфире Текнолоджис, Инк.
Publication of EA201390003A1 publication Critical patent/EA201390003A1/ru
Publication of EA026713B1 publication Critical patent/EA026713B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Способы нормализации уровней железа, лечения дефицита железа и связанных с этим расстройств, таких как анемия, согласно описанию. Описаны также фармацевтические композиции, эффективные для таких видов лечения.
EA201390003A 2010-06-09 2011-06-09 Твердая пероральная лекарственная форма для лечения дефицита железа или анемии и ее применение EA026713B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35314610P 2010-06-09 2010-06-09
PCT/US2011/039737 WO2011156563A2 (en) 2010-06-09 2011-06-09 Oral iron deficiency therapy

Publications (2)

Publication Number Publication Date
EA201390003A1 true EA201390003A1 (ru) 2013-06-28
EA026713B1 EA026713B1 (ru) 2017-05-31

Family

ID=45098662

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201390003A EA026713B1 (ru) 2010-06-09 2011-06-09 Твердая пероральная лекарственная форма для лечения дефицита железа или анемии и ее применение

Country Status (9)

Country Link
US (1) US9402864B2 (ru)
EP (1) EP2579868B1 (ru)
JP (1) JP5865903B2 (ru)
KR (1) KR101811376B1 (ru)
CN (1) CN103025327A (ru)
AU (1) AU2011264808B2 (ru)
CA (1) CA2802184C (ru)
EA (1) EA026713B1 (ru)
WO (1) WO2011156563A2 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20121350A1 (it) * 2012-07-31 2014-02-01 Alesco Srl Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
ES2657601T3 (es) 2012-08-23 2018-03-06 Emisphere Technologies, Inc. Compuestos de fenoxi alquil dietanolamina y diisopropanolamina para la administración de agentes activos
KR102084489B1 (ko) * 2018-05-18 2020-03-04 강원대학교산학협력단 열용융압출법을 이용하여 제조된 철 나노콜로이드 분산체 및 이의 용도
AU2019100771B4 (en) * 2018-07-17 2019-09-26 Ferromedica Pty Ltd Ferrous Sulphate Formulations and Uses Thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2212396A (en) 1987-12-18 1989-07-26 Procter & Gamble Dietary supplement comprising calcium and delayed release coated iron
ATE288415T1 (de) * 1999-04-05 2005-02-15 Emisphere Tech Inc Dinatrium-salze, monohydrate und ethanol-solvate
US7049283B2 (en) * 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
EP1542704A1 (en) * 2002-04-18 2005-06-22 Stephen H. Embury Method and composition for preventing pain in sickle cell patients
WO2004104018A2 (en) 2003-05-14 2004-12-02 Emisphere Technologies, Inc. Compositions for delivering peptide yy and pyy agonists
JP4702745B2 (ja) 2003-07-18 2011-06-15 株式会社林原生物化学研究所 ミネラル吸収促進剤及びその用途
KR20060109922A (ko) * 2003-10-31 2006-10-23 알자 코포레이션 가바펜틴 및 프리가발린의 개선된 흡수를 위한 조성물 및제형
WO2006076692A1 (en) * 2005-01-12 2006-07-20 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
WO2006118948A2 (en) * 2005-04-29 2006-11-09 Cubist Pharmaceuticals, Inc. Therapeutic compositions
US7585527B2 (en) * 2005-09-19 2009-09-08 Bala Venkataraman Composition and method for treating iron deficiency anemia
CA2819234A1 (en) 2011-01-07 2012-07-12 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
WO2012097155A1 (en) * 2011-01-14 2012-07-19 Chiasma Inc. Improved pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof

Also Published As

Publication number Publication date
WO2011156563A2 (en) 2011-12-15
JP2013528224A (ja) 2013-07-08
US20130230604A1 (en) 2013-09-05
AU2011264808B2 (en) 2015-01-22
CA2802184A1 (en) 2011-12-15
JP5865903B2 (ja) 2016-02-17
CA2802184C (en) 2019-01-08
EP2579868A4 (en) 2014-08-06
CN103025327A (zh) 2013-04-03
KR101811376B1 (ko) 2017-12-22
EP2579868B1 (en) 2018-03-07
KR20130112859A (ko) 2013-10-14
AU2011264808A1 (en) 2013-01-24
EP2579868A2 (en) 2013-04-17
WO2011156563A3 (en) 2012-02-02
EA026713B1 (ru) 2017-05-31
US9402864B2 (en) 2016-08-02

Similar Documents

Publication Publication Date Title
EA201691461A1 (ru) Определенные триазолопиридины и триазолопиразины, их композиции и способы их применения
EA201391615A1 (ru) Дейтерированные потенциаторы cftr
EA201590987A1 (ru) Соединения и способы их применения
EA201101686A1 (ru) Новые композиции для лечения шмт и связанных с ней расстройств
UA107783C2 (en) Isoindoline compounds for use in treating cancer
EA201491412A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201100138A1 (ru) 4-феноксиметилпиперидины в качестве модуляторов активности gpr119
EA201300471A1 (ru) Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3
UA115983C2 (uk) Інгібітори днк-пк
EA201590165A1 (ru) Сдерживающие злоупотребление фармацевтические композиции для контролируемого высвобождения
EA201491766A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA201290919A1 (ru) Индазольные соединения и их применение
EA201170349A1 (ru) Модуляторы mif
EA201291356A1 (ru) Пиперидиноновые производные как ингибиторы mdm2 для лечения рака
EA201200473A1 (ru) Замещенные (гетероарилметил)тиогидантоины
EA201290836A1 (ru) Связанные бис-арильные арилтриазолоны и их применение
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
EA201201665A1 (ru) Новые соединения
IN2013CN01340A (ru)
EA201100750A1 (ru) Замещенные диоксопиперидинилфталимидные производные
EA201290322A1 (ru) Лечение желудочно-кишечных расстройств
EA201200570A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA201171435A1 (ru) Твердые фармацевтические композиции и способы их получения
EA201101479A1 (ru) Новые p2x7r антагонисты и их применение

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU